{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:24:41Z","timestamp":1770510281129,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"vor","delay-in-days":364,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2018]]},"DOI":"10.6061\/clinics\/2017\/e455","type":"journal-article","created":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T07:55:12Z","timestamp":1543737312000},"page":"e455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Relationship between the Asp1104His polymorphism of the nucleotide excision repair gene ERCC5 and treatment sensitivity to oxaliplatin in patients with advanced colorectal cancer in China"],"prefix":"10.1016","volume":"73","author":[{"given":"Jiangying","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaocheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7 Suppl","key":"10.6061\/clinics\/2017\/e455_bib1","first-page":"2023","article-title":"Screening\/early detection model for colorectal cancer","volume":"74","author":"Lieberman","year":"1994","journal-title":"Why screen? Cancer"},{"issue":"6","key":"10.6061\/clinics\/2017\/e455_bib2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.cgh.2016.09.148","article-title":"Recent Discoveries in the Genetics of Familial Colorectal Cancer and Polyposis","volume":"15","author":"Valle","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.6061\/clinics\/2017\/e455_bib3","first-page":"177","article-title":"Colorectal cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.6061\/clinics\/2017\/e455_bib4","first-page":"397","article-title":"Neurotoxicity outcomes in a population-based cohort of elderly patients treated with adjuvant oxaliplatin for colorectal cancer","volume":"16","author":"Raphael","year":"2017","journal-title":"Clin Colorectal Cancer"},{"issue":"7","key":"10.6061\/clinics\/2017\/e455_bib5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1185\/03007995.2011.573544","article-title":"Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population","volume":"27","author":"Canbay","year":"2011","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.6061\/clinics\/2017\/e455_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevOncog.v14.i1.10","article-title":"Lynch syndrome and related familial colorectal cancers","volume":"14","author":"Abdel-Rahman","year":"2008","journal-title":"Crit Rev Oncog"},{"issue":"1","key":"10.6061\/clinics\/2017\/e455_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1158\/1078-0432.CCR-06-1256","article-title":"Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors","volume":"13","author":"Aaltonen","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"1-2","key":"10.6061\/clinics\/2017\/e455_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mrfmmm.2007.02.002","article-title":"XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer","volume":"619","author":"Hansen","year":"2007","journal-title":"Mutat Res"},{"issue":"10","key":"10.6061\/clinics\/2017\/e455_bib9","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00384-011-1222-8","article-title":"Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies","volume":"26","author":"Zhang","year":"2011","journal-title":"Int J Colorectal Dis"},{"issue":"19","key":"10.6061\/clinics\/2017\/e455_bib10","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.7314\/APJCP.2014.15.19.8383","article-title":"The ERCC1 C118T polymorphism predicts clinical outcomes of colorectal cancer patients receiving oxaliplatin-based chemotherapy: a meta-analysis based on 22 studies","volume":"15","author":"Qian","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"issue":"Suppl 1","key":"10.6061\/clinics\/2017\/e455_bib11","first-page":"E83","article-title":"DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy","volume":"51","author":"Liu","year":"2012","journal-title":"Mol Carcinog"},{"key":"10.6061\/clinics\/2017\/e455_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jinorgbio.2017.04.022","article-title":"Copper transporter 1 in human colorectal cancer cell lines: effects of endogenous and modified expression on oxaliplatin cytotoxicity","volume":"177","author":"Cui","year":"2017","journal-title":"J Inorg Biochem"},{"issue":"6","key":"10.6061\/clinics\/2017\/e455_bib13","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.6061\/clinics\/2017\/e455_bib14","first-page":"186","article-title":"ERCC1 C118T associates with response to FOLFOX4 chemotherapy in colorectal cancer patients in Han Chinese","volume":"5","author":"Chai","year":"2012","journal-title":"Int J Clin Exp Med"},{"issue":"19","key":"10.6061\/clinics\/2017\/e455_bib15","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1002\/cncr.26036","article-title":"Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified","volume":"117","author":"Brouquet","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"10.6061\/clinics\/2017\/e455_bib16","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s12032-014-0942-3","article-title":"No association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case-control study","volume":"31","author":"Moghtit","year":"2014","journal-title":"Med Oncol"},{"issue":"1","key":"10.6061\/clinics\/2017\/e455_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2014.05.025","article-title":"Association of single nucleotide polymorphisms of ERCC1 and XPF with colorectal cancer risk and interaction with tobacco use","volume":"548","author":"Hou","year":"2014","journal-title":"Gene"},{"issue":"7","key":"10.6061\/clinics\/2017\/e455_bib18","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.7314\/APJCP.2012.13.7.3465","article-title":"GSTP1, ERCC1 and ERCC2 polymorphisms, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in colorectal cancer in Chinese population","volume":"13","author":"Li","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.6061\/clinics\/2017\/e455_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/srep06700","article-title":"Association study between XPG Asp1104His polymorphism and colorectal cancer risk in a Chinese population","volume":"4","author":"Du","year":"2014","journal-title":"Sci Rep"},{"issue":"6","key":"10.6061\/clinics\/2017\/e455_bib20","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/jid.2011.35","article-title":"ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanoma","volume":"131","author":"Schrama","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.6061\/clinics\/2017\/e455_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11033-009-9698-9","article-title":"Association and impact of XPG Asp 1104 His gene polymorphism in HIV 1 disease progression to AIDS among north Indian HIV seropositive individuals","volume":"37","author":"Sobti","year":"2010","journal-title":"Mol Biol Rep"},{"issue":"7","key":"10.6061\/clinics\/2017\/e455_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036293","article-title":"Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis","volume":"7","author":"Zhu","year":"2012","journal-title":"PLoS One"},{"key":"10.6061\/clinics\/2017\/e455_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1471-2407-11-101","article-title":"The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development","volume":"11","author":"Rouissi","year":"2011","journal-title":"BMC Cancer"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222005944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222005944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:52:24Z","timestamp":1761720744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222005944"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322018000100296&lng=en&nrm=iso&tlng=en","label":"SCIELO"},{"URL":"https:\/\/www.clinicsjournal.com\/article\/relationship-between-the-asp1104his-polymorphism-of-the-nucleotide-excision-repair-gene-ercc5-and-treatment-sensitivity-to-oxaliplatin-in-patients-with-advanced-colorectal-cancer-in-china\/","label":"CLINICS"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":23,"alternative-id":["S1807593222005944"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2017\/e455","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between the Asp1104His polymorphism of the nucleotide excision repair gene ERCC5 and treatment sensitivity to oxaliplatin in patients with advanced colorectal cancer in China","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2017\/e455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e455"}}